-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LPvj2CbV86bMK9yaOf+Gbjy8uJ6NZn3IrreTikmsyixlkpou/HBQSozHO0DrSsPs I9zrU1Wr7v7wUpyr1rtEKg== 0001209191-10-052947.txt : 20101103 0001209191-10-052947.hdr.sgml : 20101103 20101103164251 ACCESSION NUMBER: 0001209191-10-052947 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101101 FILED AS OF DATE: 20101103 DATE AS OF CHANGE: 20101103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BREITMEYER JAMES B CENTRAL INDEX KEY: 0001244823 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33103 FILM NUMBER: 101161947 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CADENCE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001333248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8584361400 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0303 4 2010-11-01 0 0001333248 CADENCE PHARMACEUTICALS INC CADX 0001244823 BREITMEYER JAMES B C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 EVP, CMO common stock 2010-11-01 4 M 0 7000 3.20 A 17000 D common stock 2010-11-01 4 S 0 7000 9.00 D 10000 D common stock 2010-11-02 4 M 0 18000 3.20 A 28000 D common stock 2010-11-02 4 S 0 18000 9.0476 D 10000 D stock option (right to buy) 3.20 2010-11-01 4 M 0 7000 D 2006-08-14 2016-08-13 common stock 7000 147250 D stock option (right to buy) 3.20 2010-11-02 4 M 0 18000 D 2006-08-14 2016-08-13 common stock 18000 129250 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2010. This transaction was executed in multiple trades at prices ranging from a low of $8.95 to a high of $9.23. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Not applicable to this transaction. Hazel M. Aker Attorney-in-fact 2010-11-03 -----END PRIVACY-ENHANCED MESSAGE-----